Related Experiment Video
Updated: Aug 10, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Anticoagulant management during percutaneous coronary intervention for a patient with antithrombin deficiency
Shun Kitamura1, Kota Komiyama1, Kazuyuki Yahagi1
1Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan.
Insights
This case study details a successful cardiac intervention for a patient with antithrombin deficiency and acute coronary syndrome. The strategy involved heparin and antithrombin concentrate, preventing complications.
Area of Science:
- Cardiology
- Hematology
Background:
- Antithrombin deficiency is a rare condition with limited data on cardiac interventions.
- Managing anticoagulation during percutaneous coronary intervention (PCI) in these patients presents unique challenges.
Observation:
- A 62-year-old male with a history of thrombosis presented with acute coronary syndrome (ACS).
- Diagnosis included elevated troponin T, indicating acute myocardial infarction.
- The patient had known antithrombin deficiency.
Findings:
- Coronary intervention was performed using a combination of heparin and antithrombin concentrate.
- The procedure was successful, with no reported thrombosis or bleeding complications.
Implications:
- This case provides a potential anticoagulant management strategy for PCI in patients with antithrombin deficiency.
- The findings may guide future clinical decisions and research in managing this rare patient population.
Abstract:
Previous reports on cardiac intervention in cases with antithrombin deficiency are extremely limited. We report a case of acute coronary syndrome with antithrombin deficiency in a 62-year-old man with multiple histories of thrombosis. He had worsening chest pain, and laboratory data showed an elevated level of troponin T, suggesting acute myocardial infarction. Currently, there is no fixed anticoagulation strategy for coronary intervention in patients with antithrombin deficiency. In this case, we performed coronary intervention with heparin in addition to antithrombin concentrate. The intervention was successfully performed without thrombosis or bleeding complications.
Learning Objective:
Antithrombin deficiency is a rare disorder and data about coronary intervention for cases with antithrombin deficiency are limited. We successfully performed intervention with our anticoagulant management and it would be beneficial for future reference.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care

